Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3690071015 | Trastuzumab 150 mg powder for solution for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3690073017 | Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
53210901000001113 | Trastuzumab 150mg powder for solution for infusion vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Is a | Product containing trastuzumab | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Murine-human monoclonal immunoglobulin G antibody | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Biological agent | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Trastuzumab | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for infusion solution | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Is a | Product containing trastuzumab in parenteral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has presentation strength numerator value | 150 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has basis of strength substance | Trastuzumab | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has precise active ingredient | Trastuzumab | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Is a | Product containing only trastuzumab in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | VMP prescribing status (attribute) | Caution - AMP level prescribing advised | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | solutioninfusion.intravenous ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Intravenous route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Is a | Trastuzumab | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has active ingredient | Trastuzumab | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has unit of presentation | Vial | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has manufactured dose form | Powder for infusion solution | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has specific active ingredient | Trastuzumab | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has dispensed dose form | Powder for infusion solution | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely trastuzumab 150 milligram/1 vial powder for conventional release solution for injection | Has dispensed dose form | Powder for conventional release solution for infusion | true | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets